Publicaciones en colaboración con investigadores/as de Southern Illinois University School of Medicine (1)

2022

  1. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

    The Lancet, Vol. 400, Núm. 10367, pp. 1927-1937